Home › Funds › DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt › EW

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt position in EW

EDWARDS LIFESCIENCES CORP · Health Care

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt reported holding 10,700,967 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$923.7M, representing 1.14% of its reported portfolio and ranking #24 among its reported holdings. DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.70M sh
Reported value held$923.71M
Portfolio Weight1.14%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt's EW position evolved

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt first disclosed a stake in EW in Q3 2023 at 1,458,617 shares (US$101.1M). The position peaked in Q2 2026 at 13,002,965 shares, worth US$1.18B. Across 13 filings, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,700,967 shares valued at US$923.7M — a reduction of -2,301,998 shares quarter over quarter.. Notable position changes include a 72% trim in Q3 2024 (shares rose 12% over the following quarter), a 5596% increase in Q1 2025 (shares rose 8% over the following quarter), a 111% increase in Q2 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.46M $101.05M New
Q4 2023 488.62K $37.26M Reduce
Q1 2024 182.60K $17.45M Reduce
Q2 2024 159.58K $14.74M Reduce
Q3 2024 44.65K $2.95M Reduce
Q4 2024 75.91K $5.62M Add
Q1 2025 4.32M $313.37M Add
Q2 2025 9.13M $714.01M Add
Q3 2025 9.24M $718.61M Add
Q4 2025 7.73M $659.15M Reduce
Q1 2026 12.81M $1.03B Add
Q2 2026 13.00M $1.18B Add
Q3 2026 10.70M $923.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 27 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), Ninety One UK Ltd (US$1.03B), Arrowstreet Capital (US$879.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt held EW?

DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt's current position in EW?

As of Q3 2026, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt holds 10.70M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $923.71M, representing 1.14% of its reported portfolio and ranking #24.

Has DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt been buying or selling EW?

In the latest 13F filing (Q3 2026), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt reduced its position in EW. The position peaked in Q2 2026 at 13.00M shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, Ninety One UK Ltd, Arrowstreet Capital, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.